Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	195,889	219,892	234,315	399,707	335,573	374,121
Market Cap Growth	-37.46%	-6.16%	-41.38%	19.11%	-10.30%	-10.38%
Enterprise Value	543,638	604,604	577,535	792,820	588,371	548,883
Last Close Price	673.00	776.00	960.00	1716.00	5055.00	6135.00
PS Ratio	1.41	1.47	1.56	5.10	12.76	2.94
PB Ratio	0.47	0.50	0.56	0.87	-416.12	0.54
P/TBV Ratio	1.37	1.44	1.67	1.93	-	1.19
P/FCF Ratio	-	-	-	-	-	18.75
P/OCF Ratio	-	-	-	-	-	16.60
EV/Sales Ratio	3.92	4.03	3.84	10.12	22.38	4.32
EV/EBITDA Ratio	-	-	-	-	-	76.74
EV/EBIT Ratio	-	-	-	-	-	192.99
EV/FCF Ratio	-16.43	-	-	-	-	27.50
Debt / Equity Ratio	0.30	0.26	0.30	0.20	-560.94	0.12
Debt / EBITDA Ratio	-	-	-	-	-	11.98
Debt / FCF Ratio	-	-	-	-	-	4.29
Asset Turnover	0.22	0.25	0.25	0.14	0.04	0.17
Inventory Turnover	1.70	1.88	1.90	1.85	1.55	5.37
Quick Ratio	0.33	0.57	0.53	0.85	0.07	3.11
Current Ratio	0.67	1.19	1.15	2.35	0.24	5.11
Return on Equity (ROE)	-27.41%	-23.40%	-22.14%	-50.45%	-34.60%	-5.41%
Return on Assets (ROA)	-9.41%	-9.37%	-9.94%	-13.57%	-9.13%	0.24%
Return on Capital (ROIC)	-11.07%	-10.30%	-10.86%	-14.58%	-9.76%	0.26%
Return on Capital Employed (ROCE)	-	-	-	-	-	0.40%
Earnings Yield	-22.00%	-26.41%	-23.74%	-24.68%	-27.99%	-12.43%
FCF Yield	-16.89%	-26.22%	-35.71%	-33.30%	-35.50%	5.33%
Buyback Yield / Dilution	-12.87%	-9.40%	-16.69%	-16.73%	-206.64%	-24.06%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.